Unicorn Nest news
Centivo raises $51 million as more employers seek affordable, quality healthcare for their employees
– Centivo, a new health plan for self-funded employers that is anchored around leading providers of value-based care, announced today that it has raised an additional $51 million in funding.
– B Capital Group, a leading global technology investor, and Maverick co-led the round.
– Additional existing investors, including Bain Capital Ventures, Company Ventures, Define Ventures, F-Prime Capital, HarbourVest Partners, Ingleside Investors, Nassau Street Ventures, an AVG fund and various individuals also participated.
– These funds will support Centivo’s rapid growth and expansion amid increased demand from employers for health plans that are structurally built to address employee healthcare affordability.
Unicorn Nest news
Juno Medical Raises $5.4M in Seed Funding
– Juno Medical, a New York-based primary care company, raised $5.4m in seed funding.
– The round was led by Vast Ventures with participation from Atento Capital, Company Ventures, humbition, RareBreed Ventures and Lafayette Square.
– The company intends to use the funds to launch its Brooklyn location, expand its virtual care services and price transparency capabilities, and to hire new team members across the business.
Unicorn Nest news
Kenshō Health Raises $3.5M in Seed Funding
– Kenshō Health is a care navigation and provider discovery platform for holistic medicine.
– The company raised $3.5m in seed funding.
– The round was led by KB Partners, with participation from Company Ventures and Gaingels.
– All of Kenshō’s Pre-Seed investors – Crosscut, Female Founders Fund, Alumni Ventures Group, and Evolve Foundation also take a participation in the round.
– The company intends to use the funds to continue to build out its team, drive patient demand, and capture provider supply, serviced by its latest product, Care Matching.
Unicorn Nest news
Oova raises $1.2M to develop a better at-home kit for detecting a woman’s best time to conceive
– Oova officially launched its Oova Kit after receiving $1.2 million in seed funding led by BBG Ventures with participation by Company Ventures.
– The kit includes an at-home test that quantitatively measures two hormones, informing a woman — and her doctor — of her fertile days and confirming ovulation.
– The company was founded in 2017 by Amy Divaraniya, CEO, who holds a Ph.D. in biomedical sciences with a focus on genetics.
Unicorn Nest news
Octave Raises $20M in Series B Funding
– Octave, a San Francisco CA-based company which specializes in behavioral health, raised $20M in Series B funding.
– The round was led by Health Velocity Capital and joined by Cigna Ventures as well as existing investors Greycroft, Obvious Ventures, Company Ventures and Felicis Ventures.
– The company plans to use the funding for technology and clinical innovation and expansion of business operations.
Unicorn Nest news
Oso announces $8.2M Series A to simplify authorization for developers
– Oso, an early stage startup, has created an open source library for developers to make it easier to build authorization in their applications.
– The company announced an $8.2m Series A led by Sequoia with participation from SV Angel, Company Ventures, Highland Capital and numerous angel investors.
– When combined with a $2.7m seed round from 2019, it brings the total raised to $10.9m.
Unicorn Nest news
Eden Health Raises $60 Million Series C to Bring Collaborative Care Mainstream
– Eden Health announced an $80m Series C funding round to bring total investment in the company to $100m.
– The round was led by growth stage investor Insight Partners with participation from Amigos Health, Aspect Ventures, Company Ventures, Flare Capital, Flexcap Ventures, Max Ventures and PJC.
– The new capital will be used to extend its lead as the most advanced Integrated Virtual Care platform, expand its brick-and-mortar medical office footprint to several new major U.S. metropolitan areas, and build new features that allow for integrations of third-party healthcare services.